Contact OTC Dynamics on Twitter OTC Dynamics on Facebook
Custom solutions for retail traders

Tag: AZN News

$AZN LYNPARZA® (olaparib) in combination with abiraterone granted Priority Review in the US for patients with metastatic castration-resistant prostate cancer
on August 16, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
AZN
Source:
Business Wire
Read more

$AZN ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US as the first HER2-directed therapy for patients with previously treated HER2-mutant metastatic non-small cell lung cancer
on August 12, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
AZN
Source:
Business Wire
Read more

$AZN NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) Pioneering Innovative Hypertension Treatments
on August 11, 2022 News and Tags: , , , , , , , , , , , , , , , with 0 comments
Time:
12:31 PM
Symbol:
AZN
Source:
Investor Brand Network
Read more

$AZN The Power of Science to Stop a Killer
on August 8, 2022 News and Tags: , , , , , , , , , , , , , , , with 0 comments
Time:
9:05 AM
Symbol:
AZN
Source:
Investor Brand Network
Read more

$AZN TAGRISSO® plus savolitinib demonstrated 49% objective response rate in lung cancer patients with high levels of MET overexpression and/or amplification in SAVANNAH Phase II trial
on August 8, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
AZN
Source:
Business Wire
Read more

$AZN ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US as the first HER2-directed therapy for patients with HER2-low metastatic breast cancer
on August 5, 2022 News and Tags: , , , with 0 comments
Time:
8:06 PM
Symbol:
AZN
Source:
Business Wire
Read more

$AZN CALQUENCE® (acalabrutinib) tablet formulation approved in the US across current indications
on August 5, 2022 News and Tags: , , , with 0 comments
Time:
2:20 PM
Symbol:
AZN
Source:
Business Wire
Read more

$AZN ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority Review in the US for patients with HER2-low metastatic breast cancer
on July 25, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
AZN
Source:
Business Wire
Read more

$AZN Air Pollution is a Global Heart and Lung Health Concern
on July 18, 2022 News and Tags: , , , , , , , , , , , , , , , with 0 comments
Time:
11:00 AM
Symbol:
AZN
Source:
FinancialNewsMedia
Read more

$AZN AstraZeneca Shares Data at EASL and ESMO World GI for IMFINZI® (durvalumab) Combinations in Patients With Liver and Biliary Tract Cancers
on July 1, 2022 News and Tags: , , , with 0 comments
Time:
9:00 AM
Symbol:
AZN
Source:
Business Wire
Read more

$AZN IMFINZI® (durvalumab) Plus Chemotherapy Significantly Improved Pathologic Complete Response in AEGEAN Phase III Trial in Resectable Non-Small Cell Lung Cancer
on June 30, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
AZN
Source:
Business Wire
Read more

$AZN ALXN1840 Shows Rapid and Sustained Improvement in Copper Mobilization From Tissues, Potentially Closing Treatment Gaps for Wilson Disease Community
on June 23, 2022 News and Tags: , , , with 0 comments
Time:
8:35 AM
Symbol:
AZN
Source:
Business Wire
Read more

$AZN Eplontersen Met Co-Primary and Secondary Endpoints in Interim Analysis of the NEURO-TTRansform Phase III Trial for Hereditary Transthyretin-Mediated Amyloid Polyneuropathy (ATTRv-PN)
on June 21, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
AZN
Source:
Business Wire
Read more

$AZN PROpel Phase III Trial Positive Results of LYNPARZA® (olaparib) Plus Abiraterone in 1st-line Metastatic Castration-resistant Prostate Cancer Published in New England Journal of Medicine Evidence
on June 21, 2022 News and Tags: , , , with 0 comments
Time:
7:05 AM
Symbol:
AZN
Source:
Business Wire
Read more

$AZN Dow Jones Erased Gains Late in the Day, as Investors Continued to Consider Fears About Sluggish Economic Is Growth.
on June 18, 2022 News and Tags: , , , with 0 comments
Time:
3:38 PM
Symbol:
AZN
Source:
Best Stocks
Read more

$AZN Dow Jones Today: Investors Flee The Markets On The Belief That The Federal Reserve Would Choose For The First Three-quarter Point Hike
on June 14, 2022 News and Tags: , , , with 0 comments
Time:
12:18 PM
Symbol:
AZN
Source:
Best Stocks
Read more

$AZN Breakthroughs In Treating Killer Diseases Could Lengthen Life
on June 7, 2022 News and Tags: , , , , , , , , , , , , , , , with 0 comments
Time:
10:35 AM
Symbol:
AZN
Source:
FinancialNewsMedia
Read more

$AZN ENHERTU® (fam-trastuzumab deruxtecan-nxki) Reduced the Risk of Disease Progression or Death by 50% vs. Chemotherapy in Patients with HER2-Low Metastatic Breast Cancer with HR-Positive and HR-Negative Disease
on June 5, 2022 News and Tags: , , , with 0 comments
Time:
8:10 AM
Symbol:
AZN
Source:
Business Wire
Read more

$AZN CALQUENCE Plus Obinutuzumab Demonstrated Sustained Survival Benefit in 1st-line Chronic Lymphocytic Leukemia with 90% of Patients Surviving Five Years in ELEVATE-TN Trial
on June 4, 2022 News and Tags: , , , with 0 comments
Time:
10:00 AM
Symbol:
AZN
Source:
Business Wire
Read more

$AZN First Patients Dosed in IRIS Phase III Trial Evaluating Anifrolumab in Lupus Nephritis
on May 27, 2022 News and Tags: , , , with 0 comments
Time:
9:00 AM
Symbol:
AZN
Source:
Business Wire
Read more